mHealth Intelligence (10/19, Vaidya) reports, “Using telehealth to begin opioid use disorder (OUD) treatment is linked to high retention in treatment among Medicaid beneficiaries, according to a…study.” In the study, published in JAMA Network Open, “initiating buprenorphine treatment through telehealth was associated with better odds of 90-day retention in treatment in both” Kentucky and Ohio “compared with not starting treatment through telehealth. Among the individuals who initiated buprenorphine via telehealth in the second or third quarter of 2020, the proportion that continued treatment for at least 90 days was 45 percent in Kentucky and 28.5 percent in Ohio.”
Related Links:
— “Telehealth Supports OUD Treatment Retention Among Medicaid Enrollees,”Anuja Vaidya, mHealth Intelligence , October 19, 2023